Stay updated with breaking news from Vault Study Startup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, ON (PRWEB) December 16, 2021 -- Study start-up is one of the most complex and heavily regulated components of a clinical trial launch. This period
Published: Jul 06, 2021 By Vanessa Doctor, RN Peter Macdiarmid/Getty Images Global clinical research organization PAREXEL International has agreed to be taken over from Pamplona Capital Management for $8.5 billion. Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management. Parexel is dually headquartered in Newton and Durham, North Carolina and specializes in developing new innovations in medicine to improve patient health. It engages in decentralized clinical trials, regulatory consultations, and le...
Veeva, Parexel forge partnership to accelerate trials (metamorworks/iStock via Getty Images Plus) The trial technology provider and contract research organization will collaborate on tech and process solutions designed to accelerate clinical studies. Clinical research organization (CRO) Parexel and trial tech provider Veeva Systems have announced a collaboration aimed at generating ways to accelerate clinical research through the application of technological advancement and process innovation. According to the companies, part of the partnership will involve Parexel...
Parexel and Veeva Partner to Accelerate Clinical Trials Strategic collaboration to advance clinical trial technology and processes DURHAM, N.C. and BARCELONA, Spain, April 15, 2021 /PRNewswire/ -- Parexel and Veeva Systems (NYSE: VEEV) today announced a strategic collaboration to accelerate clinical trials through technology and process innovation. The unique collaboration combines the best of each company's experience across thousands of studies worldwide - Parexel as a leading clinical research organization (CRO) and Veeva as the technology innovator powering trials - to improve study effic...